data_1pi7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pi7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.5 -41.41 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.574 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.9 t -64.17 -45.93 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.11 80.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.565 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.781 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.0 mt -59.86 -49.4 77.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.955 HG12 HD12 ' A' ' 16' ' ' ILE . 67.6 t -56.01 -47.63 79.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.684 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.2 t -58.4 -55.62 21.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.96 -50.82 45.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.781 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.8 -44.79 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.706 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.955 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.32 -36.21 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.02 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.79 82.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.95 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.64 -56.08 12.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.91 -48.42 39.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.72 95.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.0 -56.46 14.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.28 -33.6 42.8 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.017 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.12 74.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.219 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.392 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.219 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.5 t . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.821 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.2 mt -52.41 -41.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.526 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.69 -47.17 80.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.567 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.86 -49.43 77.71 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.548 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.941 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.7 79.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.012 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.1 t -58.35 -55.55 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.759 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.74 45.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.1 mt -53.86 -44.78 61.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.682 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.941 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.3 -36.21 60.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.672 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.012 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.84 82.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.946 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -56.13 12.14 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.794 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.43 39.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.741 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.0 t -62.69 -46.66 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.3 t -66.02 -56.48 14.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.169 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.21 -33.63 41.99 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -69.29 -43.08 74.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.216 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.54 -46.57 71.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.394 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.216 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.4 t . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.799 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.4 mt -52.48 -41.5 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.504 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.4 t -64.11 -45.96 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.18 80.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.605 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.786 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.2 mt -59.84 -49.41 77.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.956 HG12 HD12 ' A' ' 16' ' ' ILE . 67.7 t -55.97 -47.71 79.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.643 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.027 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.33 -55.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.745 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.09 -50.77 45.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.786 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.9 mt -53.77 -44.82 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.692 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.956 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.3 -36.19 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.688 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.027 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.6 mt -67.39 -46.88 82.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.56 -56.15 12.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 15' ' ' ILE . 96.6 mt -51.8 -48.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.731 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 16' ' ' ILE . 67.9 t -62.65 -46.67 95.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.6 t -66.0 -56.47 14.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.166 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.25 -33.59 42.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.31 -43.05 74.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.247 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.47 -46.66 71.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.398 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.247 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.294 -1.812 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.795 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.39 -41.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.556 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.17 -45.91 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.17 80.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.559 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.786 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.85 -49.46 77.62 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.575 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.961 HG12 HD12 ' A' ' 16' ' ' ILE . 67.9 t -55.89 -47.7 79.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.697 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.023 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.5 t -58.41 -55.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.688 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.06 -50.75 45.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.759 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.786 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.86 -44.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.665 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.961 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.39 -36.13 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.609 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.023 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.48 -46.78 82.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.12 12.14 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.48 39.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.1 t -62.63 -46.69 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.02 -56.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.32 -33.59 43.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.29 -43.03 74.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.227 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.6 mt -54.62 -46.52 72.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.381 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.227 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.794 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.46 -41.48 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.482 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.19 80.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.775 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.87 -49.41 77.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.55 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.934 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.69 79.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.68 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 1.014 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.3 t -58.36 -55.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.13 -50.76 45.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.775 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.8 mt -53.77 -44.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.664 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.934 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.32 -36.21 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.624 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 1.014 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.41 -46.85 82.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.15 12.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.829 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.579 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.81 -48.49 38.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.732 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.65 -46.67 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.04 -56.43 14.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.31 -33.59 43.02 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.14 74.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.54 71.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.408 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.808 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.5 -41.41 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.574 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.439 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.9 t -64.17 -45.93 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.11 80.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.565 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.781 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.0 mt -59.86 -49.4 77.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.955 HG12 HD12 ' A' ' 16' ' ' ILE . 67.6 t -56.01 -47.63 79.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.684 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.02 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.2 t -58.4 -55.62 21.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.96 -50.82 45.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.781 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.8 -44.79 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.706 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.955 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.32 -36.21 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.02 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.79 82.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.95 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.64 -56.08 12.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.91 -48.42 39.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.72 95.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.0 -56.46 14.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.28 -33.6 42.8 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.017 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.12 74.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.219 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.392 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.219 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.5 t . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.821 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.2 mt -52.41 -41.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.526 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.69 -47.17 80.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.567 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.86 -49.43 77.71 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.548 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.941 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.7 79.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.012 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.1 t -58.35 -55.55 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.759 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.74 45.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.1 mt -53.86 -44.78 61.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.682 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.941 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.3 -36.21 60.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.672 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.012 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.84 82.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.946 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -56.13 12.14 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.794 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.43 39.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.741 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.0 t -62.69 -46.66 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.3 t -66.02 -56.48 14.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.169 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.21 -33.63 41.99 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -69.29 -43.08 74.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.216 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.54 -46.57 71.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.394 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.216 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.4 t . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.799 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.456 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.4 mt -52.48 -41.5 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.504 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.4 t -64.11 -45.96 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.18 80.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.605 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.786 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.2 mt -59.84 -49.41 77.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.956 HG12 HD12 ' A' ' 16' ' ' ILE . 67.7 t -55.97 -47.71 79.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.643 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.027 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.33 -55.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.745 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.09 -50.77 45.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.786 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.9 mt -53.77 -44.82 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.692 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.956 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.3 -36.19 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.688 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.027 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.6 mt -67.39 -46.88 82.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.56 -56.15 12.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.591 HD12 HG22 ' A' ' 15' ' ' ILE . 96.6 mt -51.8 -48.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.731 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG23 ' O ' ' A' ' 16' ' ' ILE . 67.9 t -62.65 -46.67 95.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.6 t -66.0 -56.47 14.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.166 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.25 -33.59 42.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.31 -43.05 74.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.247 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.47 -46.66 71.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.398 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.247 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.294 -1.812 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.795 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.39 -41.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.556 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.17 -45.91 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.17 80.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.559 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.786 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.85 -49.46 77.62 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.575 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.961 HG12 HD12 ' A' ' 16' ' ' ILE . 67.9 t -55.89 -47.7 79.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.697 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.023 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.5 t -58.41 -55.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.688 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.06 -50.75 45.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.759 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.786 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.86 -44.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.665 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.961 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.39 -36.13 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.609 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.023 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.48 -46.78 82.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.12 12.14 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.48 39.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.713 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.1 t -62.63 -46.69 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.02 -56.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.32 -33.59 43.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.29 -43.03 74.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.227 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.6 mt -54.62 -46.52 72.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.381 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.227 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.794 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.46 -41.48 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.482 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.19 80.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.775 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.87 -49.41 77.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.55 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.934 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.69 79.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.68 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 1.014 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.3 t -58.36 -55.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.13 -50.76 45.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.775 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.8 mt -53.77 -44.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.664 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.934 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.32 -36.21 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.624 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 1.014 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.41 -46.85 82.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.15 12.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.829 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.579 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.81 -48.49 38.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.732 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.725 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.65 -46.67 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.813 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.04 -56.43 14.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.31 -33.59 43.02 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.14 74.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.54 71.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.408 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.808 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.5 -41.41 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.574 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.9 t -64.17 -45.93 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.11 80.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.565 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.778 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.0 mt -59.86 -49.4 77.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.949 HG12 HD12 ' A' ' 16' ' ' ILE . 67.6 t -56.01 -47.63 79.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.684 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.001 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.2 t -58.4 -55.62 21.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.96 -50.82 45.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.778 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.8 -44.79 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.706 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.949 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.32 -36.21 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.001 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.79 82.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.95 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.64 -56.08 12.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.91 -48.42 39.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.72 95.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.0 -56.46 14.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.28 -33.6 42.8 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.017 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.12 74.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.217 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.392 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.217 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.5 t . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.821 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.2 mt -52.41 -41.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.526 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.69 -47.17 80.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.567 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.779 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.86 -49.43 77.71 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.548 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.7 79.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.1 t -58.35 -55.55 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.759 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.74 45.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.779 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.1 mt -53.86 -44.78 61.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.682 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.3 -36.21 60.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.672 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.998 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.84 82.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.946 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -56.13 12.14 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.794 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.574 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.43 39.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.741 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.0 t -62.69 -46.66 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.3 t -66.02 -56.48 14.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.169 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.21 -33.63 41.99 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -69.29 -43.08 74.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.54 -46.57 71.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.394 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.4 t . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.799 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.4 mt -52.48 -41.5 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.504 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.4 t -64.11 -45.96 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.18 80.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.605 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.2 mt -59.84 -49.41 77.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.95 HG12 HD12 ' A' ' 16' ' ' ILE . 67.7 t -55.97 -47.71 79.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.643 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.009 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.33 -55.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.745 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.09 -50.77 45.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.9 mt -53.77 -44.82 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.692 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.95 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.3 -36.19 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.688 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.009 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.6 mt -67.39 -46.88 82.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.56 -56.15 12.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 HG22 ' A' ' 15' ' ' ILE . 96.6 mt -51.8 -48.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.731 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 16' ' ' ILE . 67.9 t -62.65 -46.67 95.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.6 t -66.0 -56.47 14.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.166 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.25 -33.59 42.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.31 -43.05 74.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.246 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.47 -46.66 71.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.398 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.246 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.294 -1.812 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.795 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.39 -41.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.556 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.17 -45.91 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.17 80.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.559 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.785 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.85 -49.46 77.62 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.575 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 16' ' ' ILE . 67.9 t -55.89 -47.7 79.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.697 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 1.006 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.5 t -58.41 -55.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.688 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.06 -50.75 45.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.759 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.785 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.86 -44.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.665 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.959 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.39 -36.13 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.609 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.006 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.48 -46.78 82.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.12 12.14 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.48 39.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.1 t -62.63 -46.69 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.02 -56.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.32 -33.59 43.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.29 -43.03 74.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.227 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.6 mt -54.62 -46.52 72.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.381 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.227 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.794 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.46 -41.48 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.482 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.19 80.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.773 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.87 -49.41 77.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.55 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.933 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.69 79.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.68 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.999 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.3 t -58.36 -55.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.13 -50.76 45.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.773 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.8 mt -53.77 -44.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.664 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.933 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.32 -36.21 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.624 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.999 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.41 -46.85 82.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.15 12.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.829 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.81 -48.49 38.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.732 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.65 -46.67 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.04 -56.43 14.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.31 -33.59 43.02 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.14 74.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 1.214 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.54 71.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.408 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 1.214 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.808 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.5 -41.41 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.574 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.9 t -64.17 -45.93 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.11 80.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.565 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.778 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.0 mt -59.86 -49.4 77.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.949 HG12 HD12 ' A' ' 16' ' ' ILE . 67.6 t -56.01 -47.63 79.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.684 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.001 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.2 t -58.4 -55.62 21.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.96 -50.82 45.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.778 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.8 -44.79 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.706 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.949 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.32 -36.21 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.001 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.79 82.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.95 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.64 -56.08 12.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.91 -48.42 39.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.72 95.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.0 -56.46 14.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.28 -33.6 42.8 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.017 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.12 74.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.217 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.392 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.217 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.5 t . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.821 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.2 mt -52.41 -41.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.526 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.69 -47.17 80.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.567 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.779 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.86 -49.43 77.71 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.548 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.7 79.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.1 t -58.35 -55.55 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.759 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.74 45.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.779 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.1 mt -53.86 -44.78 61.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.682 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.3 -36.21 60.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.672 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.998 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.84 82.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.946 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -56.13 12.14 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.794 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.574 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.43 39.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.741 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.0 t -62.69 -46.66 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.3 t -66.02 -56.48 14.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.169 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.21 -33.63 41.99 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -69.29 -43.08 74.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.54 -46.57 71.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.394 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.4 t . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.799 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.4 mt -52.48 -41.5 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.504 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.4 t -64.11 -45.96 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.18 80.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.605 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.2 mt -59.84 -49.41 77.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.95 HG12 HD12 ' A' ' 16' ' ' ILE . 67.7 t -55.97 -47.71 79.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.643 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.009 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.33 -55.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.745 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.09 -50.77 45.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.9 mt -53.77 -44.82 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.692 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.95 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.3 -36.19 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.688 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.009 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.6 mt -67.39 -46.88 82.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.56 -56.15 12.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 HG22 ' A' ' 15' ' ' ILE . 96.6 mt -51.8 -48.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.731 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 16' ' ' ILE . 67.9 t -62.65 -46.67 95.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.6 t -66.0 -56.47 14.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.166 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.25 -33.59 42.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.31 -43.05 74.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.246 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.47 -46.66 71.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.398 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.246 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.294 -1.812 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.795 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.39 -41.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.556 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.17 -45.91 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.17 80.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.559 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.785 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.85 -49.46 77.62 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.575 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 16' ' ' ILE . 67.9 t -55.89 -47.7 79.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.697 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 1.006 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.5 t -58.41 -55.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.688 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.06 -50.75 45.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.759 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.785 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.86 -44.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.665 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.959 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.39 -36.13 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.609 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.006 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.48 -46.78 82.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.12 12.14 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.48 39.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.1 t -62.63 -46.69 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.02 -56.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.32 -33.59 43.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.29 -43.03 74.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.227 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.6 mt -54.62 -46.52 72.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.381 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.227 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.794 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.46 -41.48 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.482 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.19 80.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.773 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.87 -49.41 77.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.55 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.933 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.69 79.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.68 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.999 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.3 t -58.36 -55.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.13 -50.76 45.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.773 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.8 mt -53.77 -44.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.664 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.933 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.32 -36.21 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.624 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.999 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.41 -46.85 82.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.15 12.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.829 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.81 -48.49 38.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.732 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.65 -46.67 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.04 -56.43 14.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.31 -33.59 43.02 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.14 74.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 1.214 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.54 71.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.408 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 1.214 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.808 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.5 -41.41 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.574 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.9 t -64.17 -45.93 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.11 80.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.565 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.778 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.0 mt -59.86 -49.4 77.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.949 HG12 HD12 ' A' ' 16' ' ' ILE . 67.6 t -56.01 -47.63 79.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.684 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.001 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.2 t -58.4 -55.62 21.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.96 -50.82 45.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.778 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.8 -44.79 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.706 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.949 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.32 -36.21 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.001 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.79 82.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.95 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.64 -56.08 12.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.91 -48.42 39.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.72 95.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.0 -56.46 14.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.28 -33.6 42.8 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.017 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.12 74.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.217 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.392 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.217 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.5 t . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.821 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.2 mt -52.41 -41.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.526 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.69 -47.17 80.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.567 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.779 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.86 -49.43 77.71 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.548 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.7 79.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.1 t -58.35 -55.55 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.759 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.74 45.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.779 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.1 mt -53.86 -44.78 61.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.682 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.3 -36.21 60.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.672 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.998 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.84 82.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.946 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -56.13 12.14 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.794 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.574 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.43 39.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.741 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.0 t -62.69 -46.66 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.3 t -66.02 -56.48 14.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.169 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.21 -33.63 41.99 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -69.29 -43.08 74.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.54 -46.57 71.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.394 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.4 t . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.799 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.4 mt -52.48 -41.5 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.504 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.4 t -64.11 -45.96 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.18 80.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.605 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.2 mt -59.84 -49.41 77.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.95 HG12 HD12 ' A' ' 16' ' ' ILE . 67.7 t -55.97 -47.71 79.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.643 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.009 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.33 -55.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.745 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.09 -50.77 45.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.9 mt -53.77 -44.82 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.692 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.95 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.3 -36.19 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.688 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.009 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.6 mt -67.39 -46.88 82.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.56 -56.15 12.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 HG22 ' A' ' 15' ' ' ILE . 96.6 mt -51.8 -48.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.731 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 16' ' ' ILE . 67.9 t -62.65 -46.67 95.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.6 t -66.0 -56.47 14.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.166 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.25 -33.59 42.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.31 -43.05 74.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.246 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.47 -46.66 71.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.398 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.246 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.294 -1.812 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.795 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.39 -41.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.556 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.17 -45.91 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.17 80.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.559 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.785 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.85 -49.46 77.62 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.575 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 16' ' ' ILE . 67.9 t -55.89 -47.7 79.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.697 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 1.006 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.5 t -58.41 -55.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.688 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.06 -50.75 45.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.759 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.785 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.86 -44.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.665 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.959 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.39 -36.13 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.609 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.006 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.48 -46.78 82.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.12 12.14 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.48 39.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.1 t -62.63 -46.69 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.02 -56.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.32 -33.59 43.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.29 -43.03 74.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.227 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.6 mt -54.62 -46.52 72.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.381 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.227 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.794 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.46 -41.48 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.482 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.19 80.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.773 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.87 -49.41 77.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.55 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.933 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.69 79.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.68 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.999 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.3 t -58.36 -55.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.13 -50.76 45.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.773 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.8 mt -53.77 -44.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.664 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.933 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.32 -36.21 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.624 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.999 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.41 -46.85 82.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.15 12.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.829 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.81 -48.49 38.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.732 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.65 -46.67 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.04 -56.43 14.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.31 -33.59 43.02 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.14 74.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 1.214 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.54 71.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.408 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 1.214 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.808 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.1 mt -52.5 -41.41 36.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.574 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.441 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.9 t -64.17 -45.93 94.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.474 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.71 -47.11 80.67 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.565 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.778 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.0 mt -59.86 -49.4 77.83 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.606 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.949 HG12 HD12 ' A' ' 16' ' ' ILE . 67.6 t -56.01 -47.63 79.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.684 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.001 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.2 t -58.4 -55.62 21.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.692 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -68.96 -50.82 45.87 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.797 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.778 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.8 -44.79 60.99 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.706 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.949 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.32 -36.21 60.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.001 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.79 82.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.95 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.64 -56.08 12.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.839 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.91 -48.42 39.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.762 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.66 -46.72 95.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.1 t -66.0 -56.46 14.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.148 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.28 -33.6 42.8 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.793 -1.094 . . . . 0.0 111.017 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.12 74.68 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.861 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.217 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.55 71.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.326 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.392 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.217 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.5 t . . . . . 0 C--N 1.294 -1.822 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.821 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.449 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.2 mt -52.41 -41.47 35.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.584 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.526 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.69 -47.17 80.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.567 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.779 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.1 mt -59.86 -49.43 77.71 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.548 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.939 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.7 79.68 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.656 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.998 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.1 t -58.35 -55.55 21.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.759 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.1 -50.74 45.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.742 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.779 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.1 mt -53.86 -44.78 61.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.682 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.939 HD12 HG12 ' A' ' 12' ' ' VAL . 96.7 mt -71.3 -36.21 60.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.672 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.998 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.4 -46.84 82.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.946 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.61 -56.13 12.14 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.794 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.574 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.43 39.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.741 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.0 t -62.69 -46.66 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.3 t -66.02 -56.48 14.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.151 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.169 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.21 -33.63 41.99 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.999 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.4 t -69.29 -43.08 74.56 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.215 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.54 -46.57 71.87 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.883 -1.053 . . . . 0.0 111.394 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.215 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.4 t . . . . . 0 C--N 1.294 -1.808 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.799 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.454 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.4 mt -52.48 -41.5 36.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.504 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.446 ' O ' HG23 ' A' ' 13' ' ' VAL . 68.4 t -64.11 -45.96 95.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.46 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.62 -47.18 80.24 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.605 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.782 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.2 mt -59.84 -49.41 77.81 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.592 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.95 HG12 HD12 ' A' ' 16' ' ' ILE . 67.7 t -55.97 -47.71 79.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.643 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.009 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.4 t -58.33 -55.6 21.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.745 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.09 -50.77 45.29 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.782 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.782 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.9 mt -53.77 -44.82 60.65 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.666 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.692 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.95 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.3 -36.19 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.688 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.009 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.6 mt -67.39 -46.88 82.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.56 -56.15 12.15 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.59 HD12 HG22 ' A' ' 15' ' ' ILE . 96.6 mt -51.8 -48.51 38.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.731 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 16' ' ' ILE . 67.9 t -62.65 -46.67 95.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 114.998 -1.001 . . . . 0.0 110.842 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.824 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.6 t -66.0 -56.47 14.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.166 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.25 -33.59 42.24 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 114.772 -1.104 . . . . 0.0 111.032 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.31 -43.05 74.56 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.671 -1.149 . . . . 0.0 110.879 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.246 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.47 -46.66 71.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.398 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.246 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.7 t . . . . . 0 C--N 1.294 -1.812 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.795 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.51 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.447 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.39 -41.5 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.556 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.17 -45.91 95.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -47.17 80.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.559 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.785 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.85 -49.46 77.62 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.575 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.959 HG12 HD12 ' A' ' 16' ' ' ILE . 67.9 t -55.89 -47.7 79.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.697 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 1.006 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.5 t -58.41 -55.58 21.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.688 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.06 -50.75 45.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.759 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.785 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 96.2 mt -53.86 -44.75 61.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.665 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.959 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.39 -36.13 59.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.197 -0.911 . . . . 0.0 110.609 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.006 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.48 -46.78 82.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.919 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.62 -56.12 12.14 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.561 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.85 -48.48 39.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.739 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.1 t -62.63 -46.69 95.76 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.859 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.02 -56.43 14.78 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.158 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -52.32 -33.59 43.18 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.97 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.29 -43.03 74.68 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 114.667 -1.152 . . . . 0.0 110.9 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.227 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.6 mt -54.62 -46.52 72.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.381 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.227 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.823 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.794 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.44 ' O ' HG23 ' A' ' 12' ' ' VAL . 96.0 mt -52.46 -41.48 36.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.565 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.437 ' O ' HG23 ' A' ' 13' ' ' VAL . 67.7 t -64.14 -45.91 95.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.482 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.63 -47.19 80.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.577 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.773 ' HB3' ' CD1' ' A' ' 15' ' ' ILE . 77.3 mt -59.87 -49.41 77.83 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.55 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.933 HG12 HD12 ' A' ' 16' ' ' ILE . 67.8 t -55.97 -47.69 79.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.68 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.999 ' O ' HG13 ' A' ' 17' ' ' ILE . 75.3 t -58.36 -55.55 21.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.733 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -69.13 -50.76 45.0 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.771 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.773 ' CD1' ' HB3' ' A' ' 11' ' ' LEU . 95.8 mt -53.77 -44.82 60.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.664 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.933 HD12 HG12 ' A' ' 12' ' ' VAL . 96.6 mt -71.32 -36.21 60.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.624 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.999 HG13 ' O ' ' A' ' 13' ' ' VAL . 96.7 mt -67.41 -46.85 82.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.925 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.57 -56.15 12.09 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.829 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.575 HD12 HG22 ' A' ' 15' ' ' ILE . 96.7 mt -51.81 -48.49 38.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.732 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 16' ' ' ILE . 68.2 t -62.65 -46.67 95.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.816 HG23 ' O ' ' A' ' 17' ' ' ILE . 74.5 t -66.04 -56.43 14.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.157 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 90.3 t90 -52.31 -33.59 43.02 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.973 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.5 t -69.23 -43.14 74.64 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.876 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 1.214 ' O ' HG23 ' A' ' 25' ' ' VAL . 96.7 mt -54.55 -46.54 71.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.879 -1.055 . . . . 0.0 111.408 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 1.214 HG23 ' O ' ' A' ' 24' ' ' ILE . 58.6 t . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.808 -179.993 . . . . . . . . 1 1 . 1 stop_ save_